These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 13679639)
1. A novel method for modification of tumor cells with bacterial superantigen with a heterobifunctional cross-linking agent in immunotherapy of cancer. Shimizu M; Matsuzawa A; Takeda Y Mol Biotechnol; 2003 Sep; 25(1):89-94. PubMed ID: 13679639 [TBL] [Abstract][Full Text] [Related]
2. Augmentation of antitumor immunity with bacterial superantigen, staphylococcal enterotoxin B-bound tumor cells. Shimizu M; Yamamoto A; Nakano H; Matsuzawa A Cancer Res; 1996 Aug; 56(16):3731-6. PubMed ID: 8706016 [TBL] [Abstract][Full Text] [Related]
3. Construction and characterization of a novel superantigen fusion protein: bFGF/SEB. Wang L; Zhang H; Zhang S; Yu M; Yang X Cancer Invest; 2009 May; 27(4):376-83. PubMed ID: 19160106 [TBL] [Abstract][Full Text] [Related]
4. Stimulation of tumor-draining lymph node cells with superantigenic staphylococcal toxins leads to the generation of tumor-specific effector T cells. Shu S; Krinock RA; Matsumura T; Sussman JJ; Fox BA; Chang AE; Terman DS J Immunol; 1994 Feb; 152(3):1277-88. PubMed ID: 8301131 [TBL] [Abstract][Full Text] [Related]
5. Superantigen natural affinity maturation revealed by the crystal structure of staphylococcal enterotoxin G and its binding to T-cell receptor Vbeta8.2. Fernández MM; Bhattacharya S; De Marzi MC; Brown PH; Kerzic M; Schuck P; Mariuzza RA; Malchiodi EL Proteins; 2007 Jul; 68(1):389-402. PubMed ID: 17427250 [TBL] [Abstract][Full Text] [Related]
6. Intercellular adhesion molecule-1 and leukocyte function-associated antigen-3 provide costimulation for superantigen-induced T lymphocyte proliferation in the absence of a specific presenting molecule. Lamphear JG; Stevens KR; Rich RR J Immunol; 1998 Jan; 160(2):615-23. PubMed ID: 9551895 [TBL] [Abstract][Full Text] [Related]
7. Preparation and In Vitro Evaluation of Antitumor Activity of TGFαL3-SEB as a Ligand-Targeted Superantigen. Yousefi F; Mousavi SF; Siadat SD; Aslani MM; Amani J; Rad HS; Fooladi AA Technol Cancer Res Treat; 2016 Apr; 15(2):215-26. PubMed ID: 25759426 [TBL] [Abstract][Full Text] [Related]
8. Crystal structure of microbial superantigen staphylococcal enterotoxin B at 1.5 A resolution: implications for superantigen recognition by MHC class II molecules and T-cell receptors. Papageorgiou AC; Tranter HS; Acharya KR J Mol Biol; 1998 Mar; 277(1):61-79. PubMed ID: 9514739 [TBL] [Abstract][Full Text] [Related]
9. Differential effects of superantigen-induced "anergy" on priming and effector stages of a T cell-dependent antibody response. Lussow AR; MacDonald HR Eur J Immunol; 1994 Feb; 24(2):445-9. PubMed ID: 8299694 [TBL] [Abstract][Full Text] [Related]
10. Vbeta-restricted T cell adherence to endothelial cells: a mechanism for superantigen-dependent vascular injury. Brogan PA; Shah V; Klein N; Dillon MJ Arthritis Rheum; 2004 Feb; 50(2):589-97. PubMed ID: 14872503 [TBL] [Abstract][Full Text] [Related]
11. In vivo responses of CD4+ and CD8+ cells to bacterial superantigens. Herrmann T; Baschieri S; Lees RK; MacDonald HR Eur J Immunol; 1992 Jul; 22(7):1935-8. PubMed ID: 1623932 [TBL] [Abstract][Full Text] [Related]
12. Activation of mouse liver natural killer cells and NK1.1(+) T cells by bacterial superantigen-primed Kupffer cells. Dobashi H; Seki S; Habu Y; Ohkawa T; Takeshita S; Hiraide H; Sekine I Hepatology; 1999 Aug; 30(2):430-6. PubMed ID: 10421651 [TBL] [Abstract][Full Text] [Related]
13. Variable influence of MHC polymorphism on the recognition of bacterial superantigens by T cells. Wen R; Blackman MA; Woodland DL J Immunol; 1995 Aug; 155(4):1884-92. PubMed ID: 7636239 [TBL] [Abstract][Full Text] [Related]
14. MHC-specific recognition of a bacterial superantigen by weakly reactive T cells. Surman S; Deckhut AM; Blackman MA; Woodland DL J Immunol; 1994 May; 152(10):4893-902. PubMed ID: 8176210 [TBL] [Abstract][Full Text] [Related]
15. T-cell immunotherapy for human MK-1-expressing tumors using a fusion protein of the superantigen SEA and anti-MK-1 scFv antibody. Ueno A; Arakawa F; Abe H; Matsumoto H; Kudo T; Asano R; Tsumoto K; Kumagai I; Kuroki M; Kuroki M Anticancer Res; 2002; 22(2A):769-76. PubMed ID: 12014649 [TBL] [Abstract][Full Text] [Related]
16. Major histocompatibility complex class I molecule serves as a ligand for presentation of the superantigen staphylococcal enterotoxin B to T cells. Häffner AC; Zepter K; Elmets CA Proc Natl Acad Sci U S A; 1996 Apr; 93(7):3037-42. PubMed ID: 8610164 [TBL] [Abstract][Full Text] [Related]
17. Mutations affecting the superantigen activity of staphylococcal enterotoxin B. Briggs C; Garcia C; Zhang L; Guan L; Gabriel JL; Rogers TJ Immunology; 1997 Feb; 90(2):169-75. PubMed ID: 9135543 [TBL] [Abstract][Full Text] [Related]
18. MAIT cells launch a rapid, robust and distinct hyperinflammatory response to bacterial superantigens and quickly acquire an anergic phenotype that impedes their cognate antimicrobial function: Defining a novel mechanism of superantigen-induced immunopathology and immunosuppression. Shaler CR; Choi J; Rudak PT; Memarnejadian A; Szabo PA; Tun-Abraham ME; Rossjohn J; Corbett AJ; McCluskey J; McCormick JK; Lantz O; Hernandez-Alejandro R; Haeryfar SMM PLoS Biol; 2017 Jun; 15(6):e2001930. PubMed ID: 28632753 [TBL] [Abstract][Full Text] [Related]